TURNER'S SYNDROME AND TREATMENT PERSPECTIVES: AN INTEGRATIVE REVIEW

Authors

DOI:

https://doi.org/10.47820/recima21.v3i6.1519

Keywords:

Turner's syndrome, Growth hormone, Pubertal development

Abstract

Turner Syndrome (TS) is a sexual chromosomal abnormality characterized by the absence of an X chromosome (45, X, 46 X karyotype iso), chromosomal mosaicism (45, X/46, XX, XY karyotype), common in women. The aim of this study was to analyze the scientific productions about the health implications of Turner Syndrome and treatment perspectives. This is an integrative literature review (ILR), conducted by two independent reviewers, using the LILACS, PubMed and Scielo databases, using the PICo search strategy. Data analysis occurred through detailed reading of categorized articles. Were selected 6 articles using the inclusion and exclusion criteria and the results showed that the treatments used for ST are mainly Growth Hormone in conjunction with Progesterone and Estrogen, ensuring the increase in stature and pubertal development. However, the importance of early treatment is visible, as is the need for further studies on the subject, in order to expand the network of treatments for TS, providing an improvement in the quality of life of patients.

Downloads

Download data is not yet available.

Author Biographies

Amanda Caroline dos Passos Araújo

Acadêmica do curso de Enfermagem do Centro Universitário Santo Agostinho - UNIFSA.

 

Shirley Cardoso Morais

Acadêmica do curso de Enfermagem do Centro Universitário Santo Agostinho - UNIFSA.

 

Nelson Jorge Carvalho Batista

Professor do curso de Enfermagem do Centro Universitário Santo Agostinho – UNIFSA, Doutor em Biologia Celular e Molecular Aplicado a Saúde – ULBRA.

 

References

ACKERMANN, A.; BAMBA, V. Current controversies in turner syndrome: Genetic testing, assisted reproduction, and cardiovascular risks. Journal of Clinical & Translational Endocrinology, v. 1, n. 3, p. 61–65, set. 2014.

BARROS, B. A. et al., A inclusão de novas técnicas de análise citogenética aperfeiçoou o diagnóstico cromossômico da síndrome de Turner. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 53, p. 1137–1142, 1 dez. 2009.

CUI, X. et al. A basic understanding of Turner syndrome: Incidence, complications, diagnosis, and treatment. Intractable & Rare Diseases Research, v. 7, n. 4, 30 nov. 2018.

FONTELES, A. V. R. et al., Estatura final (EF) em síndrome de Turner (ST): experiência de 76 casos acompanhados na Unidade de Endocrinologia Pediátrica do Hospital de Clínicas da Universidade Federal do Paraná. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 55, p. 318–325, 1 jun. 2011.

GALVÃO, C. M. Evidence hierarchies. Acta Paulista de Enfermagem, v. 19, n. 2, p. 5–5, 1 jun. 2006.

GRAVHOLT, C. H. Epidemiological, endocrine and metabolic features in Turner syndrome. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 49, n. 1, p. 145–156, fev. 2005.

GRAVHOLT, C. H. et al., Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. American Journal of Physiology-Endocrinology and Metabolism, v. 280, n. 2, p. E308–E314, 1 fev. 2001.

HANEW, K. et al., The current status of 492 adult women with Turner syndrome: a questionnaire survey by the Foundation for Growth Science. Endocrine Journal, v. 68, n. 9, p. 1081–1089, 2021.

MENDES, K. D. S.; SILVEIRA, R. C. DE C. P.; GALVÃO, C. M. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto - Enfermagem, v. 17, n. 4, p. 758–764, dez. 2008.

NEVES, J. Síndrome de Turner: da suspeita diagnóstica ao tratamento. Disponível em: <https://pebmed.com.br/sindrome-de-turner-da-suspeita-diagnostica-ao-tratamento/>.

NUNES, M. R. et al., Diagnósticos de enfermagem na síndrome de Turner: O Mundo da Saúde, v. 45, n. s/n, p. 066–074, 10 mar. 2021.

NUSSBAUM, R.L.; McINNES, R.R.; WILLARD H.F. Thompson & Thompson Genética Médica. 8ª ed. Rio de Janeiro: Elsevier, 2016.

RAMOS, A. V.; SILVA, I. N.; GOULART, E. M. A. Turner syndrome: searching for better outcomes. Clinics, v. 63, p. 173–178, 2008.

REYES, T. M. E et al., Estudio preliminar sobre el tratamiento con hormona de crecimiento humana recombinante en el síndrome de Turner. Revista Cubana de Endocrinología, v. 24, n. 2, p. 161–175, 1 ago. 2013.

SAENGER P. (1996). Turner's syndrome. The New England journal of medicine, 335(23), 1749–1754. https://doi.org/10.1056/NEJM199612053352307.

SOUZA, M. T.; SILVA, M. D.; CARVALHO, R. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), v. 8, n. 1, p. 102-106, 2010. Disponível em: https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/abstract/?lang=pt.

WANDERLEY, C. A. P. et al., Desenvolvimento sexual e cognitivo das portadoras da síndrome de Turner Sexual and cognitive development of Turner’s syndrome porters. [s.l: s.n.]. Disponível em: <http://pepsic.bvsalud.org/pdf/cc/v2/v2a07.pdf>.

Published

13/06/2022

How to Cite

Araújo, A. C. dos P., Morais, S. C., & Batista, N. J. C. (2022). TURNER’S SYNDROME AND TREATMENT PERSPECTIVES: AN INTEGRATIVE REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 3(6), e361519. https://doi.org/10.47820/recima21.v3i6.1519